CLNN

$3.95-0.50%visit website

Clene Inc.

Market Cap

$57M

Live price × SEC shares (Nov 2, 2026)

Sector

Health Care

Industry

Biotechnology

Beta (raw)

1.06

60mo monthly vs SPY

P/E (TTM)

N/M

TTM to Sep 2026 · negative earnings

P/S (TTM)

239.0

TTM to Sep 2026 · revenue

P/B

N/M

TTM to Sep 2026 · negative equity

EV/EBITDA (TTM)

N/M

TTM to Sep 2026 · negative EBITDA

Loading…

Financial Statements

USD thousands	Q4 FY2025 Dec 31, 2025	Q1 FY2026 Mar 31, 2026	Q2 FY2026 Jun 30, 2026	Q3 FY2026 Sep 30, 2026	TTM Sep 30, 2026
Revenue	77	15	90	56	238
Cost of revenue	23.0	0.0	36.0	16.0	75.0
Research & development	5,503	329	3,471	4,447	13,750
Operating income	(7,495)	(2,061)	(5,347)	(6,347)	(21,250)
Interest expense	746	791	695	665	2,897
Pretax income	(9,226)	(8,091)	(13,424)	3,915	(26,826)
Income tax	0.00	0.00	0.00	0.00	0.00
Net income	(9,226)	(8,091)	(13,424)	3,915	(26,826)
EPS (basic) ($)		(0.69)	(1.08)	0.30	—
EPS (diluted) ($)				0.05
Weighted avg. shares (basic)		11,644	12,383	13,080
Weighted avg. shares (diluted)				14,669

Source: SEC XBRL filings (10-K, 10-Q). Per-share data in dollars; shares in thousands. Latest: 10-Q filed Nov 4, 2026, period ended Sep 30, 2026. flagged for review— withheld, failed a consistency check restated or split-adjustedhover a value for its source

Showing the last 5 quarters. 23 more quarters, back to Mar 2020, with Tormere Pro.

Corporate Events (8-K)

1 filing in 12 months · 0 with priority itemsFull history →

Filed	Items	Filing
Nov 4, 2026 accepted 8:35 AM ET	2.02Earnings release	Document SEC ↗

Signals

purchases / sales, 90d

Short Volume

27%

W/W -7.4pp

Market & Alt Data

News

Factor Profile

Pro

Pro feature

Fama-French factor analysis is available on the Pro plan.

Upgrade to Pro

Sort by

Type

Trade Date	Filed	Owner	Role	Type	Shares	Price	Value	Owned After
2026-05-12	2026-05-13	Ugwumba Chidozie	10% Owner	Sale	73.3K	$6.20	$454K	103.4K	View
2026-05-11	2026-05-13	Ugwumba Chidozie	10% Owner	Sale	22.2K	$6.75	$150K	176.7K	View
2026-05-04	2026-05-05	Ugwumba Chidozie	10% Owner	Sale	72.9K	$6.80	$496K	198.9K	View
2026-05-01	2026-05-05	Ugwumba Chidozie	10% Owner	Sale	5,795	$6.01	$35K	271.8K	View
2026-04-30	2026-04-30	Ugwumba Chidozie	10% Owner	Sale	5,736	$6.08	$35K	277.6K	View

1–5 of 62

1 / 13

Recent News

Clene Inc. (CLNN) Tops Q3 Earnings Estimates

Yahoo · 2026-11-04

Clene Reports Third Quarter 2026 Financial Results and Recent Operating Highlights

Yahoo · 2026-11-04

Clene seeks accelerated FDA approval for an ALS drug; a confirmatory trial is planned for 2027.

Stock Titan · 2026-11-04

Clene Q3 EPS $0.05 Beats $(0.45) Estimate, Sales $56.000K Miss $74.000K Estimate

Benzinga · 2026-11-04

Clene(CLNN) Stock Options Chain | Quotes & News

Moomoo · 2026-10-24

12 Health Care Stocks Moving In Tuesday's Intraday Session

Benzinga · 2026-10-20

Why 3M Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket

Benzinga · 2026-10-20

Clene Inc. (CLNN) Stock Price & News

Syfe · 2026-10-20

Clene Announces New Drug Application Submission to FDA for CNM-Au8 for the Treatment of ALS

Yahoo · 2026-10-19

HC Wainwright & Co. Reiterates Buy on Clene, Maintains $31 Price Target

Benzinga · 2026-10-19

Clene Submits New Drug Application To FDA For Accelerated Approvla Of CNM-Au8

Benzinga · 2026-10-19

Clene (NasdaqCM:CLNN) Stock Forecast & Analyst Predictions

Simply Wall St · 2026-10-19

Clene Targets Q4 FDA Filing for ALS Drug CNM-Au8, Eyes Mid-2027 Decision

Yahoo Finance · 2026-10-02

Clene to Present at Upcoming Investor Conferences

Yahoo Finance · 2026-09-22

Clene Announces Closing of $4 Million Registered Direct Offering Extending Capital Runway Beyond FDA Decision on CNM-Au8® NDA

Yahoo Finance · 2026-09-21

Informational purposes only, not investment advice.

Date	Insider	Type	Shares	Value
2026-05-12	Ugwumba Chidozie	S	73,296	$454,435.2
2026-05-11	Ugwumba Chidozie	S	22,177	$149,694.75
2026-05-04	Ugwumba Chidozie	S	72,884	$495,611.2
2026-05-01	Ugwumba Chidozie	S	5,795	$34,827.95
2026-04-30	Ugwumba Chidozie	S	5,736	$34,874.88

CLNN

Financial Statements

Corporate Events (8-K)

Signals

Factor Profile

Recent News

Clene Inc. (CLNN)

Reporting Insiders

Factor Profile

Corporate Events (8-K)